Kalbe Farma Future Growth

Future criteria checks 2/6

Kalbe Farma is forecast to grow earnings and revenue by 9.6% and 7.1% per annum respectively. EPS is expected to grow by 9% per annum. Return on equity is forecast to be 14.9% in 3 years.

Key information

9.6%

Earnings growth rate

9.0%

EPS growth rate

Pharmaceuticals earnings growth	21.5%
Revenue growth rate	7.1%
Future return on equity	14.9%
Analyst coverage	Good
Last updated	20 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:LCLA - Analysts future estimates and past financials data (IDR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	37,656,505	3,812,432	2,318,821	3,691,464	12
12/31/2025	34,913,466	3,491,398	2,125,511	3,385,518	14
12/31/2024	32,603,753	3,167,617	2,700,377	3,288,797	14
9/30/2024	32,126,890	3,080,202	3,586,588	4,956,052	N/A
6/30/2024	31,598,456	3,042,847	3,361,619	4,743,477	N/A
3/31/2024	30,943,002	2,868,591	2,604,666	3,914,467	N/A
12/31/2023	30,449,134	2,766,748	1,747,483	2,907,475	N/A
9/30/2023	30,312,738	2,961,621	1,171,758	2,172,143	N/A
6/30/2023	30,237,846	3,274,258	494,336	1,474,180	N/A
3/31/2023	29,786,958	3,403,045	240,749	1,135,214	N/A
12/31/2022	28,933,503	3,382,210	421,107	1,271,889	N/A
9/30/2022	28,344,270	3,381,401	313,176	1,099,074	N/A
6/30/2022	27,765,354	3,323,285	1,692,938	2,364,331	N/A
3/31/2022	27,261,485	3,302,038	2,005,220	2,696,856	N/A
12/31/2021	26,261,195	3,183,621	1,833,191	2,825,946	N/A
9/30/2021	25,115,512	2,993,591	2,996,737	4,002,944	N/A
6/30/2021	23,878,570	2,843,018	2,400,178	3,479,716	N/A
3/31/2021	23,332,456	2,780,456	2,813,800	3,965,497	N/A
12/31/2020	23,112,655	2,733,260	3,145,947	4,221,550	N/A
9/30/2020	22,902,507	2,618,701	2,045,808	3,469,847	N/A
6/30/2020	23,059,326	2,636,125	1,457,616	3,152,554	N/A
3/31/2020	23,063,580	2,580,962	987,889	2,903,915	N/A
12/31/2019	22,633,476	2,506,765	520,042	2,502,969	N/A
9/30/2019	22,222,813	2,568,165	650,143	2,414,095	N/A
6/30/2019	21,872,440	2,499,430	1,101,349	2,831,599	N/A
3/31/2019	21,424,910	2,462,761	1,074,438	2,634,606	N/A
12/31/2018	21,074,306	2,457,129	1,397,745	2,770,776	N/A
9/30/2018	20,770,524	2,428,630	1,065,101	2,533,889	N/A
6/30/2018	20,496,345	2,403,213	N/A	2,106,264	N/A
3/31/2018	20,298,678	2,404,792	N/A	2,108,688	N/A
12/31/2017	20,182,120	2,403,606	N/A	2,008,317	N/A
9/30/2017	20,087,979	2,376,474	N/A	1,957,670	N/A
6/30/2017	19,884,741	2,369,779	N/A	2,082,448	N/A
3/31/2017	19,722,837	2,324,750	N/A	2,233,931	N/A
12/31/2016	19,374,231	2,299,735	N/A	2,159,833	N/A
9/30/2016	19,135,808	2,207,683	N/A	2,402,394	N/A
6/30/2016	18,723,481	2,087,332	N/A	2,349,076	N/A
3/31/2016	18,190,514	2,038,815	N/A	2,171,154	N/A
12/31/2015	17,887,464	2,004,237	N/A	2,427,642	N/A
9/30/2015	17,737,870	2,078,487	N/A	2,277,535	N/A
6/30/2015	17,708,558	2,136,225	N/A	2,314,557	N/A
3/31/2015	17,548,723	2,101,577	N/A	2,504,167	N/A
12/31/2014	17,368,533	2,066,022	N/A	2,316,126	N/A
9/30/2014	17,320,906	2,040,142	N/A	1,863,426	N/A
6/30/2014	16,960,755	1,990,437	N/A	1,436,411	N/A
3/31/2014	16,578,629	1,968,549	N/A	1,092,379	N/A
12/31/2013	16,002,131	1,919,508	N/A	927,164	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LCLA's forecast earnings growth (9.6% per year) is above the savings rate (1%).

Earnings vs Market: LCLA's earnings (9.6% per year) are forecast to grow slower than the German market (20.9% per year).

High Growth Earnings: LCLA's earnings are forecast to grow, but not significantly.

Revenue vs Market: LCLA's revenue (7.1% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: LCLA's revenue (7.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: LCLA's Return on Equity is forecast to be low in 3 years time (14.9%).